## Abstract Functional disability of patients with Huntington's disease (HD) is determined by impairment of voluntary motor function rather than the presence of chorea. However, only few attempts have been made to quantify this motor impairment. By using a simple reaction time paradigm, we measured
Huntington's disease in venezuela: 7 years of follow-up on symptomatic and asymptomatic individuals
✍ Scribed by Dr. John B. Penney Jr.; Anne B. Young; Ira Shoulson; Simon Starosta-Rubenstein; S. Robert Snodgrass; Juan Sanchez-Ramos; Maria Ramos-Arroyo; Fidela Gomez; Graciela Penchaszadeh; Jose Alvir; Jesus Esteves; Iris DeQuiroz; Nelson Marsol; Humberto Moreno; P. Michael Conneally; Ernesto Bonilla; Nancy S. Wexler
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 720 KB
- Volume
- 5
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Persons symptomatic and at risk for Huntington's disease (HD) from a large extended family in the state of Zulia, Venezuela, have been followed prospectively for 7 years. Between 1981 and 1988, 593 people were examined, of whom 128 had symptomatic HD and 171 persons at risk had examination abnormalities that were insufficient to meet criteria for diagnosis. The remaining 294 had normal examinations. Abnormalities of saccadic eye movement and slowness of rapid alternating movements were the most common abnormalities found in at‐risk individuals. Thirty persons who did not meet criteria for diagnosis at their first examination have subsequently been diagnosed with symptomatic HD. Their average age at diagnosis was 33.5 ± 8.3 (SD) years. The likelihood of developing symptomatic HD within 3 years was 3% for those persons with normal first examinations, 23% for those with mildly abnormal first examinations, and 60% for those with highly abnormal first examinations. The rate of disease progression in early symptomatic cases were 1.4 ± 0.1 (SEM) points per year on the Shoulson‐Fahn functional capacity scale. Paternal or maternal inheritance did not appear to affect the rate of progression in this group of individuals. The data suggest that there is not a discrete age of onset but rather a prolonged period of time during which symptoms unfold.
📜 SIMILAR VOLUMES